151 related articles for article (PubMed ID: 22886976)
1. Inhibitory effect of live-attenuated Listeria monocytogenes-based vaccines expressing MIA gene on malignant melanoma.
Qian Y; Zhang N; Jiang P; Chen S; Chu S; Hamze F; Wu Y; Luo Q; Feng A
J Huazhong Univ Sci Technolog Med Sci; 2012 Aug; 32(4):591-597. PubMed ID: 22886976
[TBL] [Abstract][Full Text] [Related]
2. A Genetically Modified attenuated
Jia YY; Tan WJ; Duan FF; Pan ZM; Chen X; Yin YL; Jiao XA
Front Cell Infect Microbiol; 2017; 7():279. PubMed ID: 28706878
[TBL] [Abstract][Full Text] [Related]
3. Attenuated Listeria monocytogenes: a powerful and versatile vector for the future of tumor immunotherapy.
Wood LM; Paterson Y
Front Cell Infect Microbiol; 2014; 4():51. PubMed ID: 24860789
[TBL] [Abstract][Full Text] [Related]
4. Two Listeria monocytogenes vaccine vectors that express different molecular forms of human papilloma virus-16 (HPV-16) E7 induce qualitatively different T cell immunity that correlates with their ability to induce regression of established tumors immortalized by HPV-16.
Gunn GR; Zubair A; Peters C; Pan ZK; Wu TC; Paterson Y
J Immunol; 2001 Dec; 167(11):6471-9. PubMed ID: 11714814
[TBL] [Abstract][Full Text] [Related]
5. Construction and characterization of an attenuated Listeria monocytogenes strain for clinical use in cancer immunotherapy.
Wallecha A; Maciag PC; Rivera S; Paterson Y; Shahabi V
Clin Vaccine Immunol; 2009 Jan; 16(1):96-103. PubMed ID: 19020110
[TBL] [Abstract][Full Text] [Related]
6. High efficacy of a Listeria-based vaccine against metastatic breast cancer reveals a dual mode of action.
Kim SH; Castro F; Paterson Y; Gravekamp C
Cancer Res; 2009 Jul; 69(14):5860-6. PubMed ID: 19584282
[TBL] [Abstract][Full Text] [Related]
7. A Potent and Effective Suicidal
Hanson WG; Benanti EL; Lemmens EE; Liu W; Skoble J; Leong ML; Rae CS; Fassò M; Brockstedt DG; Chen C; Portnoy DA; Dubensky TW; Lauer P
Infect Immun; 2019 Aug; 87(8):. PubMed ID: 31235641
[TBL] [Abstract][Full Text] [Related]
8. A live-attenuated Listeria vaccine (ANZ-100) and a live-attenuated Listeria vaccine expressing mesothelin (CRS-207) for advanced cancers: phase I studies of safety and immune induction.
Le DT; Brockstedt DG; Nir-Paz R; Hampl J; Mathur S; Nemunaitis J; Sterman DH; Hassan R; Lutz E; Moyer B; Giedlin M; Louis JL; Sugar EA; Pons A; Cox AL; Levine J; Murphy AL; Illei P; Dubensky TW; Eiden JE; Jaffee EM; Laheru DA
Clin Cancer Res; 2012 Feb; 18(3):858-68. PubMed ID: 22147941
[TBL] [Abstract][Full Text] [Related]
9. Prophylactic and therapeutic efficacy of an attenuated Listeria monocytogenes-based vaccine delivering HPV16 E7 in a mouse model.
Jia Y; Yin Y; Duan F; Fu H; Hu M; Gao Y; Pan Z; Jiao X
Int J Mol Med; 2012 Dec; 30(6):1335-42. PubMed ID: 23027427
[TBL] [Abstract][Full Text] [Related]
10. Attenuated Listeria infection activates natural killer cell cytotoxicity to regress melanoma growth in vivo.
Shen H; Kanoh M; Maruyama S; Matsumoto A; Zhang W; Asano Y
Microbiol Immunol; 2008 Feb; 52(2):107-17. PubMed ID: 18380808
[TBL] [Abstract][Full Text] [Related]
11. Prospects and progress of Listeria-based cancer vaccines.
Bolhassani A; Naderi N; Soleymani S
Expert Opin Biol Ther; 2017 Nov; 17(11):1389-1400. PubMed ID: 28823183
[TBL] [Abstract][Full Text] [Related]
12. Development of a Listeria monocytogenes based vaccine against prostate cancer.
Shahabi V; Reyes-Reyes M; Wallecha A; Rivera S; Paterson Y; Maciag P
Cancer Immunol Immunother; 2008 Sep; 57(9):1301-13. PubMed ID: 18273616
[TBL] [Abstract][Full Text] [Related]
13. [Construction and characterization of an attenuated recombinant Listeria monocytogenes vector vaccine delivering HPV16 E7].
Jia Y; Yin Y; Tan W; Duan F; Pan Z; Chen X; Jiao XA
Sheng Wu Gong Cheng Xue Bao; 2016 May; 32(5):683-692. PubMed ID: 29019205
[TBL] [Abstract][Full Text] [Related]
14. Antitumoral effects of attenuated Listeria monocytogenes in a genetically engineered mouse model of melanoma.
Vitiello M; Evangelista M; Di Lascio N; Kusmic C; Massa A; Orso F; Sarti S; Marranci A; Rodzik K; Germelli L; Chandra D; Salvetti A; Pucci A; Taverna D; Faita F; Gravekamp C; Poliseno L
Oncogene; 2019 May; 38(19):3756-3762. PubMed ID: 30664692
[TBL] [Abstract][Full Text] [Related]
15. Central nervous system tumor immunity generated by a recombinant listeria monocytogenes vaccine targeting tyrosinase related protein-2 and real-time imaging of intracranial tumor burden.
Prins RM; Bruhn KW; Craft N; Lin JW; Kim CH; Odesa SK; Miller JF; Liau LM
Neurosurgery; 2006 Jan; 58(1):169-78; discussion 169-78. PubMed ID: 16385341
[TBL] [Abstract][Full Text] [Related]
16. Development of a live and highly attenuated Listeria monocytogenes-based vaccine for the treatment of Her2/neu-overexpressing cancers in human.
Shahabi V; Seavey MM; Maciag PC; Rivera S; Wallecha A
Cancer Gene Ther; 2011 Jan; 18(1):53-62. PubMed ID: 20725099
[TBL] [Abstract][Full Text] [Related]
17. A live attenuated Listeria monocytogenes vaccine vector expressing SIV Gag is safe and immunogenic in macaques and can be administered repeatedly.
Sciaranghella G; Lakhashe SK; Ayash-Rashkovsky M; Mirshahidi S; Siddappa NB; Novembre FJ; Velu V; Amara RR; Zhou C; Li S; Li Z; Frankel FR; Ruprecht RM
Vaccine; 2011 Jan; 29(3):476-86. PubMed ID: 21070847
[TBL] [Abstract][Full Text] [Related]
18. [
Ou Q; Chen Z; Tang J; Chen M; Zhang Y; Wang C
Sichuan Da Xue Xue Bao Yi Xue Ban; 2023 Nov; 54(6):1159-1166. PubMed ID: 38162066
[TBL] [Abstract][Full Text] [Related]
19. Attenuated Listeria monocytogenes protecting zebrafish (Danio rerio) against Vibrio species challenge.
Ding C; Liu Q; Li J; Ma J; Wang S; Dong Q; Xu D; Qiu J; Wang X
Microb Pathog; 2019 Jul; 132():38-44. PubMed ID: 30986451
[TBL] [Abstract][Full Text] [Related]
20. Induction of protective immunity to Listeria monocytogenes in neonates.
Kollmann TR; Reikie B; Blimkie D; Way SS; Hajjar AM; Arispe K; Shaulov A; Wilson CB
J Immunol; 2007 Mar; 178(6):3695-701. PubMed ID: 17339467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
